Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection

Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients

NCT05926518 ·Status: COMPLETED

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

NCT04416048 ·Status: TERMINATED ·Phase: PHASE2

Practice Variation on Antithrombotics in COVID-19

NCT04998799 ·Status: COMPLETED

Analysis of the Coagulopathy Developed by COVID-19 Infected Patients

NCT04356950 ·Status: COMPLETED

Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19

NCT04745442 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Relevance of Antithrombin Prescriptions at Strasbourg University Hospitals

NCT07276074 ·Status: RECRUITING

Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19

NCT04377997 ·Status: UNKNOWN ·Phase: PHASE2

Thrombosis and Covid-19

NCT04366778 ·Status: COMPLETED

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19

NCT04359212 ·Status: COMPLETED

Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)

NCT04730856 ·Status: COMPLETED ·Phase: NA

Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses

NCT04380779 ·Status: COMPLETED

ANTIcoagulation in Severe COVID-19 Patients

NCT04808882 ·Status: COMPLETED ·Phase: PHASE2

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients

NCT04593654 ·Status: COMPLETED

Study to Test the Accuracy of a Prototype Handheld PT/INR Device

NCT01349712 ·Status: UNKNOWN

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

NCT04918173 ·Status: RECRUITING ·Phase: PHASE3

A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

NCT02591732 ·Status: COMPLETED

Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto

NCT04393805 ·Status: COMPLETED

Thromboprophylaxis for Patients in ICU With COVID-19

NCT04623177 ·Status: COMPLETED

Retrospective Analysis for the ClotTriever Catheter to Investigate Safety and Effectiveness in the Treatment of Acute and Subacute Iliofemoral Deep Vein Thrombosis (DVT)

NCT05740410 ·Status: COMPLETED

Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications

NCT04780295 ·Status: COMPLETED

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

NCT05848713 ·Status: RECRUITING ·Phase: PHASE3

Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis

NCT00506519 ·Status: TERMINATED ·Phase: PHASE2

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

NCT05195372 ·Status: COMPLETED

Prediction of Thrombosis Using D-dimer Trends in COVID-19

NCT04827160 ·Status: COMPLETED

Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients

NCT04492254 ·Status: TERMINATED ·Phase: PHASE3